VALPROATE IN STATUS EPILEPTICUS

被引:16
作者
HOLLE, LM
GIDAL, BE
COLLINS, DM
机构
[1] UNIV WISCONSIN, SCH PHARM, DEPT NEUROL, MADISON, WI 53706 USA
[2] UNIV WISCONSIN HOSP & CLIN, SCH PHARM, DEPT NEUROL, MADISON, WI 53792 USA
关键词
D O I
10.1177/106002809502901017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In patients with intractable status epilepticus who have not responded to therapy with benzodiazepines, phenytoin, and barbiturates, valproate may be a reasonable option. Extemporaneously prepared valproate rectal suppositories or retention enemas have been given in dosages of 200-1200 mg q6h in addition to phenytoin, phenobarbital, or both in adults. The pediatric dose used was 15-20 mg/kg, in addition to phenytoin and/or phenobarbital.
引用
收藏
页码:1042 / 1044
页数:3
相关论文
共 15 条
[1]   EFFECTS OF VALPROATE IN A MODEL NERVOUS-SYSTEM (BUCCAL GANGLIA OF HELIX-POMATIA) .1. ANTIEPILEPTIC ACTIONS [J].
ALTRUP, U ;
GERLACH, G ;
REITH, H ;
SAID, MN ;
SPECKMANN, EJ .
EPILEPSIA, 1992, 33 (04) :743-752
[2]   THERAPY FOR STATUS EPILEPTICUS [J].
BLECK, TP .
CLINICAL NEUROPHARMACOLOGY, 1983, 6 (04) :255-269
[3]   BIOAVAILABILITY OF RECTALLY ADMINISTERED VALPROIC ACID SYRUP [J].
CLOYD, JC ;
KRIEL, RL .
NEUROLOGY, 1981, 31 (10) :1348-1352
[4]  
DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854
[5]  
GARNETT WR, 1993, PHARMACOTHERAPY PATH, P864
[6]  
MCLEAN MJ, 1986, J PHARMACOL EXP THER, V237, P1001
[7]   ABSORPTION RATE AND BIOAVAILABILITY OF VALPROIC ACID AND ITS SODIUM-SALT FROM RECTAL DOSAGE FORMS [J].
MOOLENAAR, F ;
GREVING, WJ ;
HUIZINGA, T .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (04) :309-315
[8]   TREATMENT OF STATUS EPILEPTICUS [J].
RAMSAY, RE .
EPILEPSIA, 1993, 34 :S71-S81
[9]   VALPROIC ACID LOADING DURING INTENSIVE MONITORING [J].
ROSENFELD, WE ;
LEPPIK, IE ;
GATES, JR ;
MIRELES, RE .
ARCHIVES OF NEUROLOGY, 1987, 44 (07) :709-710
[10]  
SNEAD OC, 1985, J PEDIATR-US, V106, P323